(Q34857146)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Global characterization of signalling networks associated with tamoxifen resistance in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Rachael A McCloy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Fabian Schmich

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Julia Gee

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Alison J Butt

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Roger J. Daly

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Brigid C Browne

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Falko Hochgräfe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jianmin Wu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jane Barraclough

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Andrew Stone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Christine S Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Caroline Roberts

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Naveid A Ali

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Alice Boulghourjian

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Rune Linding

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Lynn Farrow

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Robert I Nicholson

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sandra A O'Toole

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Robert L Sutherland

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Elizabeth A Musgrove

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

19 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

5237-5257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Biological determinants of endocrine resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

New strategies in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Postmenopausal advanced breast cancer: options for therapy after tamoxifen and aromatase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Optimal sequence of hormonotherapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Elevated Src kinase activity attenuates Tamoxifen response in vitro and is associated with poor prognosis clinically

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Functional involvement of protein kinase C-betaII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

PINA v2.0: mining interactome modules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Integrated network analysis platform for protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

S100A10 is required for the organization of actin stress fibers and promotion of cell spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

PhosphoMARCKS drives motility of mouse melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Secrets of drug resistance in NSCLC exposed by new molecular definition of EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

MARCKS: a case of molecular exaptation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

The MARCKS protein plays a critical role in phosphatidylinositol 4,5-bisphosphate metabolism and directed cell movement in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Tob-mediated cross-talk between MARCKS phosphorylation and ErbB-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the RhoA guanine nucleotide exchange factor Net1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Expression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Andromeda: a peptide search engine integrated into the MaxQuant environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

KOBAS server: a web-based platform for automated annotation and pathway identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

Cytoscape 2.8: new features for data integration and network visualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12441

21 January 2018

Identifiers

DOI

10.1111/FEBS.12441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23876235%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference